ACTIVE HALF-LIFE
2-4 days
CLASSIFICATION
Non-steroidal aromatase inhibitor
DOSAGE
2.5-5 mg/day
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Deus Medical
LAB TEST
See Document
WAREHOUSE
EU Warehouse 2
SUBSTANCE
Letrozole
Introducing FEMAMED 2.5 (Letrozole), a powerful non-steroidal aromatase inhibitor designed for effective hormonal treatment of breast cancer. As breast cancer growth is often driven by estrogens, the female sex hormones, FEMAMED 2.5 plays a crucial role in managing this condition.
This innovative medication works by significantly lowering estrogen levels in the body through the inhibition of the aromatase enzyme, which is vital for estrogen production. By doing so, FEMAMED 2.5 helps slow the progression of estrogen-dependent breast cancer, providing a vital tool in the fight against this disease.